Search
mumps virus vaccine
Generally used in combination with other vaccines
1) measles-mumps-rubella vaccine (MMR)
2) rubella-&-mumps vaccine.
Pathology:
- no evidence of emergence of resistant genotypes
Management:
- a 3rd vaccine dose around 18 years of age, with or without regular dosing in adulthood is suggested
Notes:
- vaccine protection seems to last an average of 27 years after the last dose (from mathematical models of outbreaks)
- among people with an immune response to the vaccine, 25% may lose protection by 8 years, 50% by 19 years, & 75% by 38 years (not clear if this is disappearingcirculating IgG or mathematical models of outbreaks)
Related
mumps
General
live virus vaccine
References
- Lewnard JA, Grad YH
Vaccine waning and mumps re-emergence in the United States.
Sci Transl Med. 2018 Mar 21;10(433)
Vol. 10, Issue 433, eaao5945
PMID: 29563321
http://stm.sciencemag.org/content/10/433/eaao5945
Component-of
measles virus vaccine live attenuated/mumps virus vaccine/rubella virus vaccine live
measles virus vaccine live attenuated/mumps virus vaccine/rubella virus vaccine live/varicella virus vaccine